Randy Scott

Randy Scott is a seasoned leader in the biotechnology sector, currently serving as Director on the Board of Directors at BridgeBio and Talis Biomedical Corporation. They have held multiple CEO positions, including at Thinking Bench Capital, LLC, and Genomic Life. Previously, Randy was the CEO of Invitae and President & Chief Scientific Officer at Incyte Pharmaceuticals. They earned a B.S. in Chemistry from Emporia State University and a Ph.D. in Biochemistry from the University of Kansas. Throughout their career, Randy has also been involved with organizations such as Genome Medical and Freenome in various director and chairman roles.